Related Experiment Video
Updated: Jan 10, 2026

12:59
Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
Published on: July 5, 2017
13.0K
Pathological response to pembrolizumab-based neoadjuvant therapy in ER-low vs. ER-zero breast cancer: a Swedish
Sanna Steen1,2, Emelie Karlsson1,3, Ida Björnheden4
1Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Breast Cancer Research : BCR
|November 29, 2025
Abstract
No abstract available in PubMed .

